Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Reporter.
Press releases published on April 28, 2025
Modern Heart and Vascular Institute Opens New Clinic in Spring, Texas
EIN Presswire
·
April 28, 2025
Modern Heart and Vascular Institute, Cardiology Practice, Opens New Clinic in Spring, Texas SPRING, TX, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Modern Heart and Vascular Institute has announced the opening of its newest clinic in Spring, …
O Chamado a um Guia Livre e Universal
EIN Presswire
·
April 28, 2025
A N.Y. Climate Week segue o caminho deixado pelo Papa Francisco. Trabalha-se aguardando o novo Pontífice "da cooperação". ROMA, ITALY, April 28, 2025 /EINPresswire.com/ -- Em uma época marcada pelo desconcerto, rápidas transformações e um crescente …
U.S. Amputee Soccer Names 2026 World Cup Qualifiers Roster, Launches Fundraiser for Mexico
EIN Presswire
·
April 28, 2025
STONY BROOK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- The American Amputee Soccer Association is proud to announce the official roster of players who will represent the United States in the 2026 Amputee Soccer World Cup Qualifiers, to be …
OROCO FILES SHELF PROSPECTUS
GlobeNewswire
·
April 28, 2025
Vancouver, Canada, April 28, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”). is pleased to announce that it has filed and obtained a receipt for a final short form base shelf prospectus (the “Prospectus“) …
Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Lyn Cobley to its Board of Directors. Ms. Cobley has been a …
Grupo Bafar Reports First Quarter 2025 Results
GlobeNewswire
·
April 28, 2025
CHIHUAHUA, Mexico, April 28, 2025 (GLOBE NEWSWIRE) -- Grupo Bafar, S.A.B. de C.V. (BIVA: BAFARB), a leading and benchmark company in the national food sector, announced its results for the first quarter of 2025, highlighting sustained growth driven by …
Houston's Baker energy consultancy critiques post-Macondo safety of a decade later
EIN Presswire
·
April 28, 2025
During the decade following the Macondo disaster that unfolded on April 20, 2010, there was a global reassessment of offshore safety, focused on U.S. waters HOUSTON, TX, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- In its 20th report on the …
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
GlobeNewswire
·
April 28, 2025
MELBOURNE, Australia, April 29, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET1 imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide …
Oxbridge / SurancePlus to Speak during TOKEN2049 Dubai at Tokenized Capital Summit 2025 and at THE GREAT GATHER - Day 2
GlobeNewswire
·
April 28, 2025
GRAND CAYMAN, Cayman Islands, April 28, 2025 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“Oxbridge Re”), together with its subsidiary SurancePlus, is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized …
Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025
GlobeNewswire
·
April 28, 2025
NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
GlobeNewswire
·
April 28, 2025
Preclinical data to showcase the potential of regRNA-targeting to increase protein levels in a clinically meaningful way by upregulating gene expression Interim safety data including patient demographic data from all SAD cohorts of the first-in-human Phase …
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
GlobeNewswire
·
April 28, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today unveils …
SAIHEAT Limited Reports Audited Financial Results for the Year Ended December 31, 2024
GlobeNewswire
·
April 28, 2025
SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- SAIHEAT Limited (“SAIHEAT” or the “Company”) (NASDAQ: SAIH), today reported audited financial results for the fiscal year ended December 31, 2024. Financial Highlights for the Year Ended December 31, 2024 Total …
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
GlobeNewswire
·
April 28, 2025
NEW HOPE, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today …
Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025
GlobeNewswire
·
April 28, 2025
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will …
Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update
GlobeNewswire
·
April 28, 2025
- FHD-909 (LY4050784) advancing in Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Preclinical synergistic anti-tumor activity of FHD-909 in combination with pembrolizumab and KRAS …
Results of Operations for the Year Ended December 31, 2024 - American Overseas Group Limited Announces Net Income Of $9.4 Million For the Year Ended December 31, 2024
GlobeNewswire
·
April 28, 2025
HAMILTON, Bermuda, April 28, 2025 (GLOBE NEWSWIRE) -- American Overseas Group Limited (BSX: AORE.BH) (Pink Sheets: AOREF.PK) (“AOG” or the “Company”) today reported consolidated net income available to common shareholders of $9.4 million, or $200.09 per …
Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that a presentation …
Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
GlobeNewswire
·
April 28, 2025
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …
Plantro Ltd. Announces Extension of Tender Offer to Acquire up to 15% of Class A Limited Voting Shares of Information Services Corporation
GlobeNewswire
·
April 28, 2025
BRIDGETOWN, Barbados, April 28, 2025 (GLOBE NEWSWIRE) -- Plantro Ltd. (“Plantro”) today announced that it is extending its ongoing all-cash tender offer (the “Tender Offer”) to acquire up to 2,777,242 class A limited voting shares (the “Class A Shares”) in …